Symbol: DRREDDY
Month: 2025-05
Start Price: ₹1177.90
End Price: ₹1251.20
12M Return: 6.22%
6M Return: 6.22%
3M Return: 6.22%
Volatility: 0.161
Sharpe Ratio: 4.820
Max Drawdown: -0.025
Peer Correlation (DIVISLAB): -0.0758
Peer Correlation (SUNPHARMA): -0.2158
Peer Correlation (HINDUNILVR): 0.2257
Average Peer Correlation: -0.022

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Dr. Reddy's Laboratories (DRREDDY) has demonstrated a strong performance in the past 12 months, with a return of 6.22%. The stock's volatility is relatively low at 0.161, indicating a stable price movement. The Sharpe Ratio of 4.820 suggests that the returns are high compared to the risk taken. The Max Drawdown of -0.025 indicates that the stock has not experienced any significant decline in value. In terms of peer correlation, DRREDDY has a low correlation with its peers, particularly with DIVISLAB and SUNPHARMA, indicating that it may be a diversification opportunity.

**Recommendation:**

Based on the analysis, I recommend a **BUY**. The stock's strong performance, low volatility, and high Sharpe Ratio indicate that it is a good investment opportunity. Additionally, the low correlation with its peers suggests that it can provide diversification benefits to a portfolio. The Max Drawdown is also relatively low, indicating that the stock is less likely to experience a significant decline in value. Overall, DRREDDY appears to be a attractive investment opportunity for those looking to invest in the pharmaceutical sector.